Compounds > iridium radioisotopes
Page last updated: 2024-08-24

iridium radioisotopes and Cancer, Second Primary

iridium radioisotopes has been researched along with Cancer, Second Primary in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (37.50)18.2507
2000's1 (12.50)29.6817
2010's4 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, IR; Dayes, IS; Gilbert, J; Julian, JA; Levine, MN; Parpia, S; Sathya, J1
Abbott, AM; Bretzke, M; Han, LK; Kinney, M; Le, CT; Lee, C; Portschy, PR; Tuttle, TM; Washington, T1
Beriwal, S; Heron, DE; Johnson, R; Kalash, R; Kim, H; Vargo, JA; Verma, V1
Lilleby, W; Raabe, NK; Tafjord, G1
Aletti, P; Bey, P; Dartois, D; Hoffstetter, S; Kozminski, P; Luporsi, E; Malissard, L; Peiffert, D; Pernot, M1
Friedrich, RE; Krüll, A; Plambeck, K; Schmelzle, R; Schwarz, R; Thurmann, H1
Gerbaulet, A; Haie-Meder, C; Mamelle, G; Marsiglia, H; Sasso, G1
Blank, LE; Koornneef, L; Tijl, JW1

Trials

2 trial(s) available for iridium radioisotopes and Cancer, Second Primary

ArticleYear
Long-Term Results of a Randomized Trial Comparing Iridium Implant Plus External Beam Radiation Therapy With External Beam Radiation Therapy Alone in Node-Negative Locally Advanced Cancer of the Prostate.
    International journal of radiation oncology, biology, physics, 2017, 09-01, Volume: 99, Issue:1

    Topics: Brachytherapy; Cause of Death; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Neoplasms, Second Primary; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Analysis; Time Factors; Treatment Outcome

2017
Prospective multicenter trial evaluating balloon-catheter partial-breast irradiation for ductal carcinoma in situ.
    International journal of radiation oncology, biology, physics, 2013, Nov-01, Volume: 87, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Humans; Iridium Radioisotopes; Mastectomy, Segmental; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Prospective Studies; Radiotherapy Dosage; Treatment Outcome

2013

Other Studies

6 other study(ies) available for iridium radioisotopes and Cancer, Second Primary

ArticleYear
Extended (5-year) outcomes of accelerated partial breast irradiation using MammoSite balloon brachytherapy: patterns of failure, patient selection, and dosimetric correlates for late toxicity.
    International journal of radiation oncology, biology, physics, 2014, Feb-01, Volume: 88, Issue:2

    Topics: Aged; Aged, 80 and over; Brachytherapy; Breast Neoplasms; Female; Follow-Up Studies; Humans; Incidence; Iridium Radioisotopes; Mastectomy, Segmental; Middle Aged; Neoplasms, Second Primary; Patient Selection; Radiotherapy Dosage; Retrospective Studies; Skin; Survival Rate; Telangiectasis; Treatment Outcome

2014
Implementation of high-dose-rate brachytherapy and androgen deprivation in patients with prostate cancer.
    International journal of radiation oncology, biology, physics, 2012, Jul-01, Volume: 83, Issue:3

    Topics: Aged; Androgen Antagonists; Brachytherapy; Combined Modality Therapy; Compartment Syndromes; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Grading; Neoplasms, Second Primary; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy, Conformal; Treatment Outcome; Urination Disorders

2012
Salvage irradiation by brachytherapy of velotonsillar squamous cell carcinoma in a previously irradiated field: results in 73 cases.
    International journal of radiation oncology, biology, physics, 1994, Jul-01, Volume: 29, Issue:4

    Topics: Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Evaluation Studies as Topic; Female; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasms, Second Primary; Oropharynx; Salvage Therapy; Tonsillar Neoplasms

1994
[Salvage therapy of advanced squamous cell carcinoma of the mouth cavity and oropharynx. Results of interstitial high-dose-rate brachytherapy combined with ablative tumor surgery].
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 1997, Volume: 173, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Iridium Radioisotopes; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Oropharyngeal Neoplasms; Radiotherapy Dosage; Retrospective Studies; Salvage Therapy; Time Factors

1997
Brachytherapy for T1-T2 floor-of-the-mouth cancers: the Gustave-Roussy Institute experience.
    International journal of radiation oncology, biology, physics, 2002, Apr-01, Volume: 52, Issue:5

    Topics: Analysis of Variance; Brachytherapy; Female; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Mouth Floor; Mouth Neoplasms; Neoplasm Staging; Neoplasms, Second Primary; Retrospective Studies; Survival Rate; Treatment Failure

2002
Recurrent hemangiopericytoma and brachytherapy.
    Documenta ophthalmologica. Advances in ophthalmology, 1992, Volume: 82, Issue:1-2

    Topics: Adult; Brachytherapy; Female; Hemangiopericytoma; Humans; Iridium Radioisotopes; Neoplasms, Second Primary; Orbital Neoplasms

1992